The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type
- PMID: 15378033
- DOI: 10.1038/nsmb834
The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type
Abstract
Post-translational modification with the ubiquitin-related protein SUMO1 requires the E1 enzyme Aos1-Uba2 and the E2 enzyme Ubc9. Distinct E3 ligases strongly enhance modification of specific targets. The SUMO E3 ligase RanBP2 (also known as Nup358) has no obvious similarity to RING- or HECT-type enzymes. Here we show that RanBP2's 30-kDa catalytic fragment is a largely unstructured protein. Despite two distinct but partially overlapping 79-residue catalytic domains, one of which is sufficient for maximal activity, RanBP2 binds to Ubc9 in a 1:1 stoichiometry. The identification of nine RanBP2 and three Ubc9 side chains that are important for RanBP2-dependent SUMOylation indicates largely hydrophobic interactions. These properties distinguish RanBP2 from all other known E3 ligases, and we speculate that RanBP2 exerts its catalytic effect by altering Ubc9's properties rather than by mediating target interactions.
Similar articles
-
The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.Mol Cell. 2012 May 11;46(3):287-98. doi: 10.1016/j.molcel.2012.02.017. Epub 2012 Mar 29. Mol Cell. 2012. PMID: 22464730
-
The nucleoporin RanBP2 has SUMO1 E3 ligase activity.Cell. 2002 Jan 11;108(1):109-20. doi: 10.1016/s0092-8674(01)00633-x. Cell. 2002. PMID: 11792325
-
Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.Nature. 2005 Jun 2;435(7042):687-92. doi: 10.1038/nature03588. Nature. 2005. PMID: 15931224 Free PMC article.
-
Performing in vitro sumoylation reactions using recombinant enzymes.Methods Mol Biol. 2009;497:187-99. doi: 10.1007/978-1-59745-566-4_12. Methods Mol Biol. 2009. PMID: 19107418 Review.
-
Protein interactions in the sumoylation cascade: lessons from X-ray structures.FEBS J. 2008 Jun;275(12):3003-15. doi: 10.1111/j.1742-4658.2008.06459.x. Epub 2008 May 17. FEBS J. 2008. PMID: 18492068 Review.
Cited by
-
Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases.Cells. 2023 Dec 20;13(1):8. doi: 10.3390/cells13010008. Cells. 2023. PMID: 38201212 Free PMC article. Review.
-
Targeting zinc finger domains with small molecules: solution structure and binding studies of the RanBP2-type zinc finger of RBM5.Chembiochem. 2011 Dec 16;12(18):2837-45. doi: 10.1002/cbic.201100582. Chembiochem. 2011. PMID: 22162216 Free PMC article.
-
Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.Cell. 2008 Apr 4;133(1):103-15. doi: 10.1016/j.cell.2008.01.045. Cell. 2008. PMID: 18394993 Free PMC article.
-
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.Nat Rev Mol Cell Biol. 2010 Dec;11(12):861-71. doi: 10.1038/nrm3011. Nat Rev Mol Cell Biol. 2010. PMID: 21102611 Free PMC article. Review.
-
Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction.Physiol Rev. 2014 Oct;94(4):1249-85. doi: 10.1152/physrev.00008.2014. Physiol Rev. 2014. PMID: 25287864 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
